Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Im­muno­log­i­cal Medicines for Rab­bits

Immunological veterinary medicinal products, including vaccines, are authorised for rabbits.

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Er­avac

Rab­bit Haem­or­rhag­ic Dis­ease (RHD)

Lab­o­ra­to­rios Hipra S.A., Spanien

EU/2/16/199-/001-002 26.09.2016 Kaninchen

EPAR: Er­avac

FA­TROVAX RHD

Rab­bit Haem­or­rhag­ic Dis­ease (RHD)

FA­TRO S.p.A., Ital­ien

EU/2/21/275 16.08.2021 Kaninchen

EPAR: Fa­trovax RHD

Filavac VHD K C+V

Rab­bit Haem­or­rhag­ic Dis­ease (RHD)

FILAVIE, Rous­say, Frankre­ich

PEI.V.11900.01.1 13.03.2017 Kaninchen

No­bi­vac Myxo-RHD PLUS

Myx­o­matose, Rab­bit Haem­or­rhag­ic Dis­ease (RHD)

In­ter­vet In­ter­na­tion­al B.V., Nieder­lande

EU/2/19/244/001-003 19.11.2019 Kaninchen

EPAR: No­bi­vac Myxo-RHD Plus

RI­KA-VACC Duo

Myx­o­matose, Hä­m­or­rhagis­che Krankheit (RHD)

Ecuphar NV, Bel­gien

PEI.V.03071.01.1 12.06.2008 Kaninchen

RI­KA-VACC Myxo sc

Myx­o­matose

Ecuphar NV, Bel­gien

PEI.V.03157.01.1 12.06.2008 Kaninchen

Yur­vac RHD

Rab­bit Haem­or­rhag­ic Dis­ease (RHD)

Lab­o­ra­to­rios Hipra, S.A., Spanien

EU/2/23/298 11.09.2023 Kaninchen

EPAR: Yur­vac RHD

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 514 in BAnz AT 01.03.2024 B8.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 04.03.2024